Tomkiel Melissa M.
Co-CEO and General Counsel at BLDE
- Sold, on record
- $2.5M
- Dollars the filings state
- Form 4 sales
- 14
- Latest Jun 8, 2026
- Form 144 notices
- 10
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- BLDEStrata Critical Medical, Inc.Co-CEO and General Counsel
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 144 notice BLDENoticeNov 29, 2024 2024
Filed to sell 44,621 shares ($196k)
Tomkiel Melissa M., Officer
10b5-1 planFirst sale on recordFiling
- 2 Form 4 sale BLDERoutineNov 29, 2024 same day
Sold 111,377 shares at $4.50 ($502k)
Tomkiel Melissa M., President and General Counsel
10b5-1 planSold 9.5% of holdings ($5.3M position)1.1M shares leftFirst sale on recordFollows a Form 144Filing
- 3 Form 4 sale BLDERoutineDec 9, 2024 +10 days
Sold 22,486 shares at $5.01 ($113k)
Tomkiel Melissa M., President and General Counsel
10b5-1 planSold 2.1% of holdings ($5.3M position)1M shares leftFollows a Form 144Filing
- 4 Form 144 notice BLDENoticeJun 9, 2025 +182 days
Filed to sell 100,000 shares ($380k)
Tomkiel Melissa M., Officer
10b5-1 plan2.4x usual sizeFiling
- 5 Form 4 sale BLDERoutineJun 9, 2025 same day
Sold 100,000 shares at $4.08 ($408k)
Tomkiel Melissa M., President and General Counsel
10b5-1 planSold 8% of holdings ($5.1M position)1.2M shares left2.4x usual sizeFollows a Form 144Filing
- 6 Form 144 notice BLDENoticeAug 4, 2025 +56 days
Filed to sell 47,995 shares ($181k)
Tomkiel Melissa M., Officer
10b5-1 plan1.2x usual sizeFiling
- 7 Form 4 sale BLDERoutineAug 4, 2025 same day
Sold 47,995 shares at $4.94 ($237k)
Tomkiel Melissa M., President and General Counsel
10b5-1 planSold 4% of holdings ($5.9M position)1.1M shares left1.2x usual sizeFollows a Form 144Filing
- 8 Form 4 sale BLDENo planJun 8, 2026 +308 days
Sold 29,730 shares at $5.87 ($175k)
Tomkiel Melissa M., Co-CEO and General Counsel
No 10b5-1 planSold 1.5% of holdings ($11.3M position)1.9M shares left0.6x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (24)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jun 8, 2026 | Jun 10, 2026 | BLDE | Co-CEO and General Counsel | Form 4 sale | 29,730 | $175k | 1.5% | No plan | SEC |
| Aug 4, 2025 | Aug 5, 2025 | BLDE | President and General Counsel | Form 4 sale | 47,995 | $237k | 4.0% | Routine | SEC |
| Aug 4, 2025 | Aug 4, 2025 | BLDE | Officer | Form 144 notice | 47,995 | $181k | Notice | SEC | |
| Jun 9, 2025 | Jun 11, 2025 | BLDE | President and General Counsel | Form 4 sale | 100,000 | $408k | 8.0% | Routine | SEC |
| Jun 9, 2025 | Jun 9, 2025 | BLDE | Officer | Form 144 notice | 100,000 | $380k | Notice | SEC | |
| Dec 9, 2024 | Dec 11, 2024 | BLDE | President and General Counsel | Form 4 sale | 22,486 | $113k | 2.1% | Routine | SEC |
| Nov 29, 2024 | Nov 29, 2024 | BLDE | President and General Counsel | Form 4 sale | 111,377 | $502k | 9.5% | Routine | SEC |
| Nov 29, 2024 | Nov 29, 2024 | BLDE | Officer | Form 144 notice | 44,621 | $196k | Notice | SEC | |
| Nov 27, 2024 | Nov 27, 2024 | BLDE | Officer | Form 144 notice | 89,242 | $353k | Notice | SEC | |
| Nov 12, 2024 | Nov 13, 2024 | BLDE | President and General Counsel | Form 4 sale | 44,621 | $152k | 3.7% | Routine | SEC |
| Nov 12, 2024 | Nov 12, 2024 | BLDE | Officer | Form 144 notice | 44,621 | $171k | Notice | SEC | |
| Apr 3, 2024 | Apr 5, 2024 | BLDE | President and General Counsel | Form 4 sale | 22,836 | $75k | 1.7% | No plan | SEC |
| Apr 3, 2024 | Apr 4, 2024 | BLDE | Officer | Form 144 notice | 11,734 | $38k | Notice | SEC | |
| Mar 14, 2024 | Mar 15, 2024 | BLDE | President and General Counsel | Form 4 sale | 51,825 | $139k | 4.0% | No plan | SEC |
| Mar 13, 2024 | Mar 13, 2024 | BLDE | Officer | Form 144 notice | 58,464 | $138k | Notice | SEC | |
| Dec 15, 2023 | Dec 15, 2023 | BLDE | President and General Counsel | Form 4 sale | 35,969 | $112k | 2.8% | No plan | SEC |
| Dec 13, 2023 | Dec 13, 2023 | BLDE | Officer | Form 144 notice | 44,347 | $112k | Notice | SEC | |
| Oct 6, 2023 | Oct 6, 2023 | BLDE | President and General Counsel | Form 4 sale | 37,656 | $92k | 2.9% | No plan | SEC |
| Oct 4, 2023 | Oct 4, 2023 | BLDE | Officer | Form 144 notice | 41,296 | $88k | Notice | SEC | |
| Jul 10, 2023 | Jul 10, 2023 | BLDE | President and General Counsel | Form 4 sale | 91,080 | $348k | 6.6% | Unusual | SEC |
| Jul 6, 2023 | Jul 6, 2023 | BLDE | Officer | Form 144 notice | 108,187 | $345k | Notice | SEC | |
| Apr 10, 2023 | Apr 11, 2023 | BLDE | President and General Counsel | Form 4 sale | 39,951 | $116k | 2.8% | No plan | SEC |
| Jan 9, 2023 | Jan 12, 2023 | BLDE | President and General Counsel | Form 4 sale | 5,139 | $18k | 0.4% | Plan not stated | SEC |
| Oct 6, 2022 | Oct 11, 2022 | BLDE | President and General Counsel | Form 4 sale | 4,366 | $17k | 1.0% | Plan not stated | SEC |